Salah-Eddin Al-Batran, Director Institute of Clinical Research at University Cancer Center Franfkurt, shared a post on LinkedIn:
“It was a pleasure to welcome Giovanni Melillo, Osama Rahma, and the AstraZeneca team for inspiring discussions about ongoing and future collaborations in oncology research.
We truly value AstraZeneca’s commitment to academic–industry partnerships that accelerate innovation and translate science into better patient outcomes.
Looking forward to building on today’s great energy and exploring new joint initiatives!”
More posts featuring Salah-Eddin Al-Batran on OncoDaily.